Eur J Pediatr Surg 2021; 31(05): 445-451
DOI: 10.1055/s-0040-1716884
Original Article

Esophageal Atresia and Associated Duodenal Atresia: A Cohort Study and Review of the Literature

Maria Enrica Miscia
1   Pediatric Surgery Unit, Department of Medicine and Aging Science, University Gabriele d'Annunzio of Chieti Pescara Pescara, Italy
,
2   Department of Pediatric Surgery, Department of Medicine and Aging Science, University Gabriele d'Annunzio of Chieti and Pescara, Chieti, Abruzzo, Italy
3   Department of Pediatric Surgery, Ospedale Civile dello Spirito Santo, Pescara, Abruzzo, Italy
,
Dacia Di Renzo
4   UO Chirurgia Pediatrica, Ospedale Civile dello Spirito Santo, Pescara, Abruzzo, Italy
,
Angela Riccio
2   Department of Pediatric Surgery, Department of Medicine and Aging Science, University Gabriele d'Annunzio of Chieti and Pescara, Chieti, Abruzzo, Italy
,
1   Pediatric Surgery Unit, Department of Medicine and Aging Science, University Gabriele d'Annunzio of Chieti Pescara Pescara, Italy
,
Pierluigi Lelli Chiesa
2   Department of Pediatric Surgery, Department of Medicine and Aging Science, University Gabriele d'Annunzio of Chieti and Pescara, Chieti, Abruzzo, Italy
3   Department of Pediatric Surgery, Ospedale Civile dello Spirito Santo, Pescara, Abruzzo, Italy
› Author Affiliations

Abstract

Introduction Esophageal atresia (EA) is associated with duodenal atresia (DA) in 3 to 6% of cases. The management of this association is controversial and literature is scarce on the topic.

Materials and Methods We aimed to (1) review the patients with EA + DA treated at our institution and (2) systematically review the English literature, including case series of three or more patients.

Results Cohort study: Five of seventy-four patients with EA had an associated DA (6.8%). Four of five cases (80%) underwent primary repair of both atresia, one of them with gastrostomy placement (25%). One of five cases (20%) had a delayed diagnosis of DA. No mortality has occurred. Systematic Review: Six of six-hundred forty-five abstract screened were included (78 patients). Twenty-four of sixty-eight (35.3%) underwent primary correction of EA + DA, and 36/68 (52.9%) underwent staged correction. Nine of thirty-six (25%) had a missed diagnosis of DA. Thirty-six of sixty-eight underwent gastrostomy placement. Complications were observed in 14/36 patients (38.9 ± 8.2%). Overall mortality reported was 41.0 ± 30.1% (32/78 patients), in particular its incidence was 41.7 ± 27.0% after a primary treatment and 37.0 ± 44.1% following a staged approach.

Conclusion The management of associated EA and DA remains controversial. It seems that the staged or primary correction does not affect the mortality. Surgeons should not overlook DA when correcting an EA.

Ethical Approval

Informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


Supplementary Material



Publication History

Received: 06 April 2020

Accepted: 16 August 2020

Article published online:
28 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Nabzdyk CS, Chiu B, Jackson CC, Chwals WJ. Management of patients with combined tracheoesophageal fistula, esophageal atresia, and duodenal atresia. Int J Surg Case Rep 2014; 5 (12) 1288-1291
  • 2 Miscia ME, Lauriti G, Lelli Chiesa P, Zani A. Duodenal atresia and associated intestinal atresia: a cohort study and review of the literature. Pediatr Surg Int 2019; 35 (01) 151-157
  • 3 Spitz L, Ali M, Brereton RJ. Combined esophageal and duodenal atresia: experience of 18 patients. J Pediatr Surg 1981; 16 (01) 4-7
  • 4 Dave S, Shi EC. The management of combined oesophageal and duodenal atresia. Pediatr Surg Int 2004; 20 (09) 689-691
  • 5 Fragoso AC, Ortiz R, Hernandez F, Olivares P, Martinez L, Tovar JA. Defective upper gastrointestinal function after repair of combined esophageal and duodenal atresia. J Pediatr Surg 2015; 50 (04) 531-534
  • 6 Stark Z, Patel N, Clarnette T, Moody A. Triad of tracheoesophageal fistula-esophageal atresia, pulmonary hypoplasia, and duodenal atresia. J Pediatr Surg 2007; 42 (06) 1146-1148
  • 7 Ein SH, Palder SB, Filler RM. Babies with esophageal and duodenal atresia: a 30-year review of a multifaceted problem. J Pediatr Surg 2006; 41 (03) 530-532
  • 8 Gross RE. The Surgery of Infancy and Childhood. Philadelphia: WB Saunders; 1953
  • 9 Gray SW, Skandalakis JE. Embryology for Surgeons: The Embryological Basis for Treatment of Congenital Defects. Philadelphia, PA: WB Saunders; 1972: 177-217
  • 10 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8 (05) 336-341
  • 11 National Institute for Health Research. PROSPERO International prospective register of systematic reviews. 2011 . Accessed September 1, 2020 at: https://www.crd.york.ac.uk/prospero
  • 12 Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
  • 13 Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003; 73 (09) 712-716
  • 14 Shea BJ, Reeves BC, Wells G. et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017; 358: j4008